Zoroufchi BH, Doustmohammadi H, Mokhtari T, Abdollahpour A. Benzodiazepines related sexual dysfunctions: a critical review on pharmacology and mechanism of action. Rev Int Androl. 2021;19(1):62–8.
Faubion SS, Rullo JE. Sexual dysfunction in women: a practical approach. Am Fam Physician. 2015;92(4):281–8.
Conaglen HM, Conaglen JV. Drug-induced sexual dysfunction in men and women. Aust Prescr. 2013;36:42–5.
Mohanalakshmi M, Gnana Durai WJA, Kalaimath B, Nileena NKM, Punithavath D, Gayathri K, et al. Sexual dysfunction induced by anti-psychotics and anti-depressants in Drug-Naive Patients—a comparative study. J Evid Based Med Healthc. 2017;4(24)
Stamatiou K, Margariti M, Nousi E, Mistrioti D, Lacroix R, Saridi M. Female sexual dysfunction (FSD) in women health care workers. Mater Sociomed. 2016;28(3):178.
Irfan M, Hussain NHN, Noor NM, Mohamed M, Sidi H, Ismail SB. Epidemiology of male sexual dysfunction in Asian and European regions: a systematic review. Am J Mens Health. 2020;14(4):1557988320937200.
Ponholzer A, Roehlich M, Racz U, Temml C, Madersbacher S. Female sexual dysfunction in a healthy Austrian cohort: prevalence and risk factors. Eur Urol. 2005;47(3):366–75.
Ashton AK, Jamerson BD, Weinstein WL, Wagoner C. Antidepressant-related adverse effects impacting treatment compliance: results of a patient survey. Curr Ther Res. 2005;66(2):96–106.
Finn SE, Bailey JM, Schultz RT, Faber R. Subjective utility ratings of neuroleptics in treating schizophrenia. Psychol Med. 1990;20(4):843–8.
Gordijn R, Teichert M, Nicolai MPJ, Elzevier HW, Guchelaar H-J. Adverse drug reactions on sexual functioning: a systematic overview. Drug Discov Today. 2019;24(3):890–7.
Gordijn R, Nicolai MPJ, Elzevier HW, Guchelaar H-J, Teichert M. An estimation of patients at potential risk for drug-induced sexual dysfunction using pharmacy dispensing data. Fam Pract. 2021;38(3):292–8.
Graziottin A. Similarities and differences between female and male sexual functions and dysfunctions. J Men’s Heal Gend. 2004;1(1):71–6.
Hayes RD, Dennerstein L, Bennett CM, Fairley CK. What is the “true” prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact? J Sex Med. 2008;5(4):777–87.
Cerejo AC. Disfunção sexual feminina: prevalência e factores relacionados. Rev Port Med Geral e Fam. 2006;22(6):701–20.
Chen C-H, Lin Y-C, Chiu L-H, Chu Y-H, Ruan F-F, Liu W-M, et al. Female sexual dysfunction: Definition, classification, and debates. Taiwan J Obstet Gynecol. 2013;52(1):3–7.
Chen L, Shi G, Huang D, Li Y, Ma C, Shi M, et al. Male sexual dysfunction: a review of literature on its pathological mechanisms, potential risk factors, and herbal drug intervention. Biomed Pharmacother. 2019;112:108585.
Jackson RE, Bellamy MC. Antihypertensive drugs. Contin Educ Anaesth Crit Care Pain. 2015;15(6):280–5.
Tehrani FR, Farahmand M, Simbar M, Afzali HM. Factors associated with sexual dysfunction; a population based study in Iranian reproductive age women. Arch Iran Med. 2014;17(10):679–84.
Wincze JP, Bach AK, Barlow DH. Sexual dysfunction. New York: The Guilford Press; 2008.
Camacho ME, Reyes-Ortiz CA. Sexual dysfunction in the elderly: age or disease? Int J Impot Res. 2005;17(1):S52–6.
Lewis RW, Fugl-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, Lizza E, et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med. 2004;1(1):35–9.
Vanwesenbeeck I, Bakker F, Gesell S. Sexual health in the Netherlands: Main results of a population survey among Dutch adults. Int J Sex Health. 2010;22(2):55–71.
Kedde H, Donker G, Leusink P, Kruijer H. The incidence of sexual dysfunction in patients attending Dutch general practitioners. Int J Sex Health. 2011;23(4):269–77.
Clayton A, Keller A, McGarvey EL. Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord. 2006;91(1):27–32.
Peixoto MM, Nobre P. Prevalence and sociodemographic predictors of sexual problems in Portugal: a population-based study with women aged 18 to 79 years. J Sex Marital Ther. 2015;41(2):169–80.
Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010;57(5):804–14.
Bonierbale M, Tignol J. The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin. 2003;19(2):114–24.
Sporn NJ, Smith KB, Pirl WF, Lennes IT, Hyland KA, Park ER. Sexual health communication between cancer survivors and providers: how frequently does it occur and which providers are preferred? Psychooncology. 2015;24(9):1167–73.
Reese JB, Sorice K, Beach MC, Porter LS, Tulsky JA, Daly MB, et al. Patient-provider communication about sexual concerns in cancer: a systematic review. J Cancer Surviv. 2017;11(2):175–88.
van Ek GF, Krouwel EM, Nicolai MP, Bouwsma H, Ringers J, Putter H, et al. Discussing sexual dysfunction with chronic kidney disease patients: practice patterns in the office of the nephrologist. J Sex Med. 2015;12(12):2350–63.
van Hees PJM, van der Plas AA, van Ek GF, Putter H, Den Oudsten BL, den Ouden MEM, et al. Discussing sexuality with patients with Parkinson’s disease: a survey among Dutch neurologists. J Neural Transm. 2017;124(3):361–8.
Korse NS, Nicolai MPJ, Both S, Vleggeert-Lankamp CLA, Elzevier HW. Discussing sexual health in spinal care. Eur Spine J. 2016;25(3):766–73.
Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F, et al. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry. 2001;62:10–21.
Manolis A, Doumas M. Antihypertensive treatment and sexual dysfunction. Curr Hypertens Rep. 2012;14(4):285–92.
Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RHG. N itric o xide, e rectile d ysfunction and beta-blocker treatment (mr noed study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol. 2007;34(4):327–31.
Doumas M, Tsakiris A, Douma S, Grigorakis A, Papadopoulos A, Hounta A, et al. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients. Asian J Androl. 2006;8(2):177–82.
Düsing R. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press. 2003;12(Suppl 2):29–34.
Rothmore J. Antidepressant-induced sexual dysfunction. Med J Aust. 2020;212(7):329–34.
Healy D. Citizen petition: sexual side effects of SSRIs and SNRIs. Int J risk Saf Med. 2018;29(3–4):135.
Ekhart C, de Vries T, van Hunsel F. Psychiatric adverse drug reactions in the paediatric population. Arch Dis Child. 2020;105(8):749–55.
Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 1999;20(2):109–17.
World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. World Health Organization; 2013. p 3
GIPdatabase. Drug Information System of the Dutch Health Care Insurance Board. https://www.gipdatabank.nl. Accessed 19 Feb 2021.
Kant A, van Hunsel F, van Puijenbroek E. Numbers of spontaneous reports: how to use and interpret? Br J Clin Pharmacol. 2022;88(3):1365–8.
Quinta Gomes AL, Nobre PJ. Prevalence of sexual problems in Portugal: results of a population-based study using a stratified sample of men aged 18 to 70 years. J Sex Res. 2014;51(1):13–21.
Khazaie H, Rezaie L, Payam NR, Najafi F. Antidepressant-induced sexual dysfunction during treatment with fluoxetine, sertraline and trazodone; a randomized controlled trial. Gen Hosp Psychiatry. 2015;37(1):40–5.
Apantaku-Olajide T, Gibbons P, Higgins A. Drug-induced sexual dysfunction and mental health patients’ attitude to psychotropic medications. Sex Relatsh Ther. 2011;26(2):145–55.
Montejo AL, Montejo L, Baldwin DS. The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management. World Psychiatry. 2018;17(1):3–11.
Montejo AL, Prieto N, de Alarcón R, Casado-Espada N, de la Iglesia J, Montejo L. Management strategies for antidepressant-related sexual dysfunction: a clinical approach. J Clin Med. 2019;8(10):1640.
Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2010;7(4):1668–86.
Michels KB. Problems assessing nonserious adverse drug reactions: antidepressant drug therapy and sexual dysfunction. Pharmacother. 1999;19(4):424–9.
Walker PW, Cole JO, Gardner EA, Hughes AR, Johnston JA, Batey SR, et al. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry. 1993;54(12):459–65.
Montgomery SA, Baldwin DS, Riley A. Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord. 2002;69(1–3):119–40.
de Vries ST, Denig P, Ekhart C, Burgers JS, Kleefstra N, Mol PGM, et al. Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: an explorative observational study. Br J Clin Pharmacol. 2019;85(7):1507–15.
Watson S, Caster O, Rochon PA, den Ruijter H. Reported adverse drug reactions in women and men: aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine. 2019;17:100188.
Trenque T, Maura G, Herlem E, Vallet C, Sole E, Auriche P, et al. Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: an example of underreporting. Drug Saf. 2013;36(7):515–9.
Labbate LA. Psychotropics and sexual dysfunction: the evidence and treatments. Sex Dysfunct. 2008;29:107–30.
D’Incau P, Lapeyre-Mestre M, Carvajal A, Donati M, Salado I, Rodriguez L, et al. No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain. Fundam Clin Pharmacol. 2014;28(3):342–8.
Stahl SM. Mechanism of action of serotonin selective reuptake inhibitors: serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord. 1998;51(3):215–35.
Jing E, Straw-Wilson K. Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: a narrative literature review. Ment Health Clin. 2016;6(4):191–6.
Montejo-Gonzalez AL, Llorca G, Izquierdo JA, Ledesma A, Bouso M, Calcedo A, et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther. 1997;23:176–94.
Choi JH, Hwa JS, Kam SC, Jeh SU, Hyun JS. Effects of tamsulosin on premature ejaculation in men with benign prostatic hyperplasia. World J Mens Health. 2014;32(2):99–104.
Bijiwerkingen Centrum Lareb. Tamsulosin and erectile dysfunction. Bijiwerkingen Centrum Lareb; 2014.
De Graaf L, Brouwers A, Diemont WL. Is decreased libido associated with the use of HMG-CoA-reductase inhibitors? Br J Clin Pharmacol. 2004;58(3):326–8.
Schooling CM, Au Yeung SL, Freeman G, Cowling BJ. The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials. BMC Med. 2013;11(1):1–9.
Cai X, Tian Y, Wu T, Cao C-X, Bu S-Y, Wang K-J. The role of statins in erectile dysfunction: a systematic review and meta-analysis. Asian J Androl. 2014;16(3):461.
Valpey R, Kucherer S, Nguyen J. Sexual dysfunction in female cancer survivors: a narrative review. Gen Hosp Psychiatry. 2019;60:141–7.
Reese JB, Sorice K, Lepore SJ, Daly MB, Tulsky JA, Beach MC. Patient-clinician communication about sexual health in breast cancer: a mixed-methods analysis of clinic dialogue. Patient Educ Couns. 2019;102(3):436–42.
Wallerstedt SM, Brunlöf G, Sundström A. Rates of spontaneous reports of adverse drug reactions for drugs reported in children. Drug Saf. 2011;34(8):669–82.
Labbate LA, Lare SB. Sexual dysfunction in male psychiatric outpatients: validity of the Massachusetts General Hospital Sexual Functioning Questionnaire. Psychother Psychosom. 2001;70(4):221–5.
Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol. 2009;29(3):259–66.
Barlow DH. Causes of sexual dysfunction: the role of anxiety and cognitive interference. In: Barlow DH, editor. The neurotic paradox. Routledge; 2020. p. 183–98.
Wallwiener CW, Wallwiener L-M, Seeger H, Mück AO, Bitzer J, Wallwiener M. Prevalence of sexual dysfunction and impact of contraception in female German medical students. J Sex Med. 2010;7(6):2139–48.
Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry. 2002;63(4):15499.
Landén M, Högberg P, Thase ME. Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine. J Clin Psychiatry. 2005;66(1):8892.
Chinchilla Alfaro K, van Hunsel F, Ekhart C. Persistent sexual dysfunction after SSRI withdrawal: a scoping review and presentation of 86 cases from The Netherlands. Expert Opin Drug Saf. https://doi.org/10.1080/14740338.2022.2007883